A STUDY OF SERUM CASA AND CA-125 LEVELS IN PATIENTS WITH OVARIAN-CARCINOMA

被引：0
|
作者：
MEISEL, M
STRAUBE, W
WEISE, J
BURKHARDT, B
机构：
来源：
ARCHIVES OF GYNECOLOGY AND OBSTETRICS | 1995年 / 256卷 / 01期
关键词：
CASA; CA-125; OVARIAN CARCINOMA;
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
The assays of Cancer Associated Serum Antigen (CASA) and CA 125 were assessed in the management of patients with ovarian cancer. It was shown that CASA is sensitive to ovarian carcinoma, and both CASA and CA 125 are more useful when used in conjunction.
引用
收藏
页码：9 / 15
页数：7
相关论文
共 50 条
  • [1] IS CA-125 MONITORING USEFUL IN PATIENTS WITH EPITHELIAL OVARIAN-CARCINOMA AND PREOPERATIVE NEGATIVE CA-125 SERUM LEVELS
    SEVELDA, P
    ROSEN, A
    DENISON, U
    BARRADA, M
    SPONA, J
    SALZER, H
    GYNECOLOGIC ONCOLOGY, 1991, 43 (02) : 154 - 158
  • [2] AN INITIAL ANALYSIS OF PREOPERATIVE SERUM CA-125 LEVELS IN PATIENTS WITH EARLY STAGE OVARIAN-CARCINOMA
    ZURAWSKI, VR
    KNAPP, RC
    EINHORN, N
    KENEMANS, P
    MORTEL, R
    OHMI, K
    BAST, RC
    RITTS, RE
    MALKASIAN, G
    GYNECOLOGIC ONCOLOGY, 1988, 30 (01) : 7 - 14
  • [3] CA-125 AND MAM-6 IN SERUM AND TUMOR OF PATIENTS WITH OVARIAN-CARCINOMA
    KOLDOVSKY, U
    WARGALLA, U
    HILKENS, J
    FELDHAMMER, B
    KROIZIN, S
    BROSS, M
    HILGERS, J
    TUMORDIAGNOSTIK & THERAPIE, 1986, 7 (03) : 125 - 128
  • [4] USE OF CA-125 TO PREDICT SURVIVAL OF PATIENTS WITH OVARIAN-CARCINOMA
    RUSTIN, GJS
    GENNINGS, JN
    NELSTROP, AE
    COVARRUBIAS, H
    LAMBERT, HE
    BAGSHAWE, KD
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) : 1667 - 1671
  • [5] EVALUATION OF SERUM CA-125 LEVELS IN THE MONITORING OF RESPONSE TO CHEMOTHERAPY IN EPITHELIAL OVARIAN-CARCINOMA (EOC)
    QUARANTA, M
    COVIELLO, M
    MICELLI, G
    CASAMASSIMA, A
    ABBATE, I
    CORREALE, M
    LORUSSO, V
    BRITISH JOURNAL OF CANCER, 1989, 59 (02) : 322 - 322
  • [6] CA-125 IN THE MONITORING OF RESPONSE TO CHEMOTHERAPY OF OVARIAN-CARCINOMA
    QUARANTA, M
    LORUSSO, V
    COVIELLO, M
    MICELLI, G
    CASAMASSIMA, A
    INTERNATIONAL JOURNAL OF CANCER, 1988, : 68 - 70
  • [7] CA-125 LEVELS IN PATIENTS WITH OVARIAN-CARCINOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    CIOBANU, N
    RUNOWICZ, CD
    WIERNIK, PH
    STRAUMAN, T
    SHERIDAN, C
    BAST, RC
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 160 (02) : 354 - 355
  • [8] ELEVATED SERUM CA-125 LEVELS IN PATIENTS WITH OVARIAN FIBROTHECOMAS
    SCHNEIDER, J
    AVILA, M
    BARRENETXEA, G
    MONTOYA, F
    RODRIGUEZESCUDERO, FJ
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (03) : 481 - 481
  • [9] CLINICAL USE OF CA-125 AND CA-19-9 IN PATIENTS WITH OVARIAN-CARCINOMA
    NEGISHI, Y
    IKEHATA, N
    AZUMA, T
    OKABE, K
    KOBAYASHI, K
    NUTAHARA, Y
    NAKAMURA, F
    SATO, H
    AKIYA, K
    TUMOUR BIOLOGY, 1986, 7 (04): : 265 - 265
  • [10] EVALUATION OF THE CLINICAL RELEVANCE OF THE ASSAY FOR CA-125 IN THE MANAGEMENT OF PATIENTS WITH OVARIAN-CARCINOMA
    PUGH, RP
    DALBOW, MH
    RAJU, R
    ZIDAR, B
    ZAMMERILLA, CF
    TUMOUR BIOLOGY, 1985, 6 (04): : 419 - 419
12345